RESPONSE OF A CHILD WITH FAMILIAL DYSREGULATION OF THE COMPLEMENT SYSTEM TO ANTI-C5 ANTIBODY

被引：0
|
作者：
Elnour, Ibtisam [1 ]
El-Naggari, Mohamed [1 ]
机构：
[1] Sultan Qaboos Univ Hosp, Muscat, Oman
来源：
PEDIATRIC NEPHROLOGY | 2017年 / 32卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
P-219
引用
收藏
页码：1748 / 1748
页数：1
相关论文
共 50 条
  • [1] C3-glomerulopathy caused by a dysregulation of the alternative pathway of the complement system: improvement with the anti-C5 monoclonal antibody eculizumab
    Romano, F.
    Frassoni, E.
    Siegenthaler, G.
    Tschumi, S.
    Bucher, S. B.
    Simonetti, G. D.
    SWISS MEDICAL WEEKLY, 2015, 145 : 35 - 35
  • [2] Clinical complement inhibition by the anti-C5 antibody Eculizumab: Update on clinical trials
    Roeth, A.
    ONKOLOGIE, 2010, 33 : 283 - 283
  • [3] Eculizumab - Humanized anti-C5 monoclonal antibody
    Harding, J
    DRUGS OF THE FUTURE, 2004, 29 (07) : 673 - 676
  • [4] Targeted anti-C5 drug neutralizes complement in the joint
    Emma Leah
    Nature Reviews Rheumatology, 2012, 8 (4) : 186 - 186
  • [5] Development and characterisation of a novel anti-C5 monoclonal antibody capable of inhibiting complement in multiple species
    Zelek, Wioleta
    Morgan, B. Paul
    MOLECULAR IMMUNOLOGY, 2018, 102 : 231 - 231
  • [6] Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv.
    Thomas, TC
    Rollins, SA
    Rother, RP
    Giannoni, MA
    Hartman, SL
    Elliott, EA
    Nye, SH
    Matis, LA
    Squinto, SP
    Evans, MJ
    MOLECULAR IMMUNOLOGY, 1996, 33 (17-18) : 1389 - 1401
  • [7] DECADE Trial: Inhibition of theterminal complement system using the anti-C5 antibody eculizumab for the treatment of cold agglutinin disease (CAD)
    Roeth, A.
    Huettmann, A.
    Duehrsen, U.
    ONKOLOGIE, 2010, 33 : 112 - 112
  • [8] Complement inhibition with an anti-C5 monoclonal antibody prevents hyperacute rejection in a xenograft heart transplantation model
    Wang, H
    Rollins, SA
    Gao, ZH
    Garcia, B
    Zhang, Z
    Xing, JJ
    Li, L
    Kellersmann, R
    Matis, LA
    Zhong, R
    TRANSPLANTATION, 1999, 68 (11) : 1643 - 1651
  • [9] Anti-C5 monoclonal antibody: A novel anti-inflammatory agent
    不详
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1996, 6 (11) : 1229 - 1230
  • [10] Of Mice and Men: Terminal Complement Inhibition With Anti-C5 Monoclonal Antibodies
    Woodle, E. S.
    Baldwin, W. M., III
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (11) : 2277 - 2278
12345